GenomeDx Biosciences Closes Series A

Baird Venture Partners and aeris CAPITAL co-led a Series A round for molecular diagnostic company GenomeDx Biosciences Inc. CD Ventures and individual investors also participated in the financing round. The size of the round was not disclosed. GenomeDx develops molecular diagnostic tests and clinical support tools for cancer medicine.

North AmericaUSBriefs